The activation of healthy donor-derived NK cells in vitro by interleukin 2 (IL-2), interleukin 12 (IL-12), interleukin 15 (IL-15), and interleukin 18 (IL-18) results in more effective lysis of ALL blasts [125,126,127]. The gene discussed is IL18; the disease is acute lymphoblastic leukemia.